Flu Avert in Canada

Heska Corporation announced Sept. 24 that it has received approval from the Canadian Food Inspection Agency to sell Flu Avert I.N., an intranasal influenza vaccine, in Canada. Heska has granted Novartis Animal Health Canada, Inc., exclusive distribution rights to market and sell the vaccine.

Heska anticipates a positive reception for the product in Canada, given the vaccine's success in

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In
Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners